1. Cross, A.S., Opal, S.M., Warren, H.S., Palardy, J.E., Glaser, K., Parejo, A., and Bhattacharjee, A.K., Active Immunization with a Detoxified Escherichia coli J5 Lipopolysaccharide Group B Meningococcal Outer Membrane Protein Complex Vaccine Protects Animals from Experimental Sepsis, J. Infect. Dis., 2001, no. 183, pp. 1079–1086.
2. Astiz, M.E. and Rackow, E.C., Septic Shock, Lancet, 1998, no. 361, pp. 1501–1505.
3. Dinarello, C., Cytokines As Mediators in the Pathogenesis of Septic Shock, Curr. Topics Microbiol. Immunol., 1996, no. 216, pp. 133–165.
4. Ulloa, L. and Tracey, K.J., The “Cytokine Profile”: A Code for Sepsis, Trends Mol. Med., 2005, no. 11, pp. 56–63.
5. Madonna, G.S., Peterson, J.E., Ribi, E.E., and Vogel, S.N., Early-Phase Endotoxin Tolerance: Induction by Detoxified Lipid A Derivative, Monophosphoryl Lipid A, Infect. Immun., 1986, vol. 1, no. 52, pp. 6–11.